The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
|Articles|April 7, 2020
Federal Equipment Company
Author(s)Federal Equipment Company
Federal Equipment Company is a reliable resource for pharmaceutical processing and packaging equipment needs, with over 60 years of expertise working with manufacturers seeking to buy and sell used equipment.
Used Watson Marlow Flexicon aseptic filler, plugger and capper system, model FPC50, stainless steel construction, designed for speeds up to 25 vials/minute, .1 mL - 100 mL fill capacity, designed for 13 mm and 20 mm plugs and caps, accuracy up to +/- .5 % with 18" diameter rotary feed table, peristaltic feed pump, automatic vial indexing, bowl feeders for plugs and caps with plug feeder/inserter, crimp style capper and tray loading stand, with plc controls and operator interface, CE rated, 600 watt, 230 volt, part# 63-202-060, serial# 11451071, built 2011.
Federal Equipment Company
tel. +1 800.652.2466
[email protected]
Related to this article
The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.